1 The retractions came only a few months after BioMed Central.

Though many editors dislike this practice Even, it is used frequently, for a number of reasons. One is usually that in specific fields, authors could be best qualified to suggest suitable reviewers for the topic and manuscript in question. Another is normally that it makes life easier for editors: finding suitable peer reviewers who are willing to review in a timely manner can be both difficult and time consuming. A third reason could be that journals and publishers are increasingly multinational. During the past, the editor and editorial table of a journal understood both the scientific field it protected and the people employed in it, but it’s extremely difficult to become sufficiently well connected when both editors and submissions come from across the world.Discussing the effective completion of the preclinical advancement stage, Dr Walter Schmidt, director and co-founder of AFFiRiS AG stated: We’ve had PD01 evaluated in a variety of preclinical systems. All the assessments have shown that this vaccine functions against alpha-syn. In addition to histological and biochemical analyses, we have even had the opportunity to see behavioural improvements because of our vaccination. We are now starting preparations for the clinical trial of PD01 that will supplement our current scientific programmes .